Spark Therapeutics' Vision Loss Gene Therapy Heads For EU Market

 
• By John Davis
  
Jeffrey Marrazzo
Jeffrey Marrazzo, CEO of Spark Therapeutics • Source: Spark Therapeutics
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business